Please ensure Javascript is enabled for purposes of website accessibility

OrganiGram to Supply Israeli Company With Up to 6 Metric Tons of Cannabis

By David Jagielski – Jun 9, 2020 at 2:11PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The deal with medical marijuana company Canndoc could also help the OrganiGram reach other international markets.

Canadian cannabis producer OrganiGram Holdings (OGI -0.96%) announced on Tuesday that it had secured its largest international deal ever. The company will supply up to 6,000 kilograms of dried cannabis flower to Canndoc, a medical marijuana producer in Israel. Only half the sale is guaranteed; OrganiGram is obligated to deliver that much to Canndoc by Dec. 31, 2021. The buyer will have the option of deciding whether it wants to receive the rest.

For OrganiGram, the deal is about more than just the Israeli market. In January 2019, the Middle Eastern country approved the export of medical marijuana, opening up opportunities for Israeli producers to ship to other countries nearby that have legalized cannabis for medical use.

OrganiGram CEO Greg Engel stated in the press release that "the agreement with Canndoc represents an important, significant leap into the global cannabis marketplace for Organigram, allowing us to support not only medical cannabis patients in Israel but also potentially in the other major international markets that Canndoc serves."

Europe at night, from space.

Image source: Getty Images.

Coming off a lackluster quarter

In its fiscal second quarter, which ended Feb. 29, OrganiGram's net revenue fell 13.8% year over year to 23.2 million Canadian dollars. Sales in the Canadian market declined and international revenue was minimal -- just CA$200,000.

While the company notes that it has been supplying product to the Australian market, the opportunity to supply Israel and reach other markets through the deal with Canndoc could lead to much more sales growth down the road.

OrganiGram investors were bullish on the news of the deal as the pot stock was up almost 4% in late-afternoon trading Tuesday.

David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

OrganiGram Holdings Stock Quote
OrganiGram Holdings
$0.89 (-0.96%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.